Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Krummel, A. Strassburg, M. Ernst, B. Eker, H. Rath, R. Hoerster, W. Wappler, A. Glaewe, V. Schoellhorn, C. Lange (Borstel, Luebeck, Strassberg, Germany). Low frequency of drug resistant mycobacterium tuberculosis transmission among close contacts of a highly symptomatic index case. Eur Respir J 2008; 32: Suppl. 52, 2512

Member's Comments

No comment yet.

Related content which might interest you: Low frequency of mycobacterium tuberculosis (MTB) transmission among close contacts of a highly symptomatic index case Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Relationship between exposure with drug resistant tuberculosis and developing new resistant cases Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 1285 Year: 2006 RD1-epitopes response correlates with the time since first exposure in close contacts recently exposed to mycobacterium tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002 The significance of a mycobacterial isolate in a low tuberculosis prevalence setting Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Correlation of Mycobacterium tuberculosis [not]-specific and non-specific quantitative T cell IFN-γ responses with mycobacillary load in a HIV-prevalent high burden setting Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Our experience in multi drug resistant tuberculosis (MDR TB) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB Source: Eur Respir J 2009; 33: 1085-1094 Year: 2009 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 The rate of TB infection in closed contacts of smear positivepulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 646s Year: 2004 Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 The WHO strategy for TB control and elimination Source: Eur Respir Mon 2012; 58: 242-253 Year: 2012